BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Staging
25 results:

  • 1.
    Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
    J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell lung cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative consolidation-to-tumor ratio is effective in the prediction of lymph node metastasis in patients with pulmonary ground-glass component nodules.
    Chen YC; Lin YH; Chien HC; Hsu PK; Hung JJ; Huang CS; Hsieh CC; Hsu WH; Hsu HS
    Thorac Cancer; 2021 Apr; 12(8):1203-1209. PubMed ID: 33629518
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The International Association for the Study of lung cancer Thymic Tumors staging Project: The Impact of the Eighth Edition of the Union for International cancer Control and American Joint Committee on cancer TNM Stage Classification of Thymic Tumors.
    Ruffini E; Fang W; Guerrera F; Huang J; Okumura M; Kim DK; Girard N; Billè A; Boubia S; Cangir AK; Detterbeck F; Falkson C; Filosso PL; Giaccone G; Kondo K; Infante M; Lucchi M; Marino M; Marom EM; Nicholson AG; Rimner A; Rami-Porta R; Asamura H; ; ; ;
    J Thorac Oncol; 2020 Mar; 15(3):436-447. PubMed ID: 31783179
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    Bott MJ; Yang SC; Park BJ; Adusumilli PS; Rusch VW; Isbell JM; Downey RJ; Brahmer JR; Battafarano R; Bush E; Chaft J; Forde PM; Jones DR; Broderick SR
    J Thorac Cardiovasc Surg; 2019 Jul; 158(1):269-276. PubMed ID: 30718052
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The expression and significance of tumor associated macrophages and CXCR4 in non-small cell lung cancer.
    Yusen W; Xia W; Shengjun Y; Shaohui Z; Hongzhen Z
    J BUON; 2018; 23(2):398-402. PubMed ID: 29745083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage lung cancer.
    Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
    Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic Accuracy of Mediastinal Lymph Node staging Techniques in the Preoperative Assessment of Nonsmall Cell lung cancer Patients.
    Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node staging.
    Giesel FL; Schneider F; Kratochwil C; Rath D; Moltz J; Holland-Letz T; Kauczor HU; Schwartz LH; Haberkorn U; Flechsig P
    J Nucl Med; 2017 Feb; 58(2):282-287. PubMed ID: 27660141
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Racial and Ethnic Differences in lung cancer Surgical Stage: An STS Database Study.
    Weksler B; Kosinski AS; Burfeind WR; Silvestry SC; Sullivan J; D'Amico TA
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):538-43. PubMed ID: 25984780
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification.
    Kameyama K; Okumura N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Sawabata N; Okumura M; Yokoi K;
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2659-64. PubMed ID: 25173121
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [staging with 18F-FDG-PET/CT influences stage-specific survival in advanced non-small cell lung cancer (NSCLC)].
    Tönnies S; Bauer TT; Misch D; Boch C; Blum T; Bittner RC; Förster GJ; Kollmeier J
    Pneumologie; 2012 Apr; 66(4):212-7. PubMed ID: 22477481
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study.
    Naalsund A; Rostad H; Strøm EH; Lund MB; Strand TE
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):565-9. PubMed ID: 20888248
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Racial disparities on the use of invasive and noninvasive staging in patients with non-small cell lung cancer.
    Suga JM; Nguyen DV; Mohammed SM; Brown M; Calhoun R; Yoneda K; Gandara DR; Lara PN
    J Thorac Oncol; 2010 Nov; 5(11):1772-8. PubMed ID: 20881638
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer.
    Kim MS; Lee HS; Lee JM; Zo JI; Lee GK; Nam BH
    Eur J Cardiothorac Surg; 2010 Oct; 38(4):491-7. PubMed ID: 20399672
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
    De Wever W; Vankan Y; Stroobants S; Verschakelen J
    Eur Respir J; 2007 May; 29(5):995-1002. PubMed ID: 17331966
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.